These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery. Capasso C; Supuran CT Expert Opin Ther Pat; 2024 Jun; 34(6):465-474. PubMed ID: 38506448 [TBL] [Abstract][Full Text] [Related]
4. Targeting bacterial topoisomerases: how to counter mechanisms of resistance. Tse-Dinh YC Future Med Chem; 2016 Jun; 8(10):1085-100. PubMed ID: 27285067 [TBL] [Abstract][Full Text] [Related]
5. Challenges in the development of next-generation antibiotics: opportunities of small molecules mimicking mode of action of host-defense peptides. Wang M; Odom T; Cai J Expert Opin Ther Pat; 2020 May; 30(5):303-305. PubMed ID: 32149532 [No Abstract] [Full Text] [Related]
7. Mechanism of quinolone action and resistance. Aldred KJ; Kerns RJ; Osheroff N Biochemistry; 2014 Mar; 53(10):1565-74. PubMed ID: 24576155 [TBL] [Abstract][Full Text] [Related]
8. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity. Naeem A; Badshah SL; Muska M; Ahmad N; Khan K Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501 [TBL] [Abstract][Full Text] [Related]
9. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV. Metwally NH; Abdallah SO; Mohsen MMA Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481 [TBL] [Abstract][Full Text] [Related]
11. Research and development of antibiotics: insights from patents and citation network. Zhang M; Kong X; Zheng J; Wan JB; Wang Y; Hu Y; Shao R Expert Opin Ther Pat; 2016 May; 26(5):617-27. PubMed ID: 26986226 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Supuran CT; Capasso C Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966 [TBL] [Abstract][Full Text] [Related]
13. ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents. Durcik M; Tomašič T; Zidar N; Zega A; Kikelj D; Mašič LP; Ilaš J Expert Opin Ther Pat; 2019 Mar; 29(3):171-180. PubMed ID: 30686070 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial resistance to antibiotics. Noah N Epidemiol Infect; 2024 May; 152():e72. PubMed ID: 38712589 [No Abstract] [Full Text] [Related]